In a shocking development, two young baseball pitchers have been handed lengthy bans, raising questions about the sport's drug policies. But is this fair punishment or a controversial decision?
ESPN reports: Giants' Luis Custodio and free agent Luis Sierra, both promising pitchers, have been suspended for a staggering 56 games each. The reason? Positive tests for Stanozolol, a banned substance, under the minor league drug program.
Custodio, a 21-year-old left-handed pitcher, had a brief stint with the Giants Black in the Dominican Summer League, posting a 7.94 ERA in 12 relief appearances. He was signed by the San Francisco Giants in 2023, showing potential despite his recent Tommy John surgery.
Sierra, a right-hander aged 20, signed with the Baltimore Orioles last June with a $10,000 bonus. However, his short tenure with the DSL Orioles ended with a 9.95 ERA in 11 relief appearances. Sierra's suspension will commence once he joins another major league team.
But here's where it gets controversial: Stanozolol is a powerful anabolic steroid, but its presence in these players' systems could have potential medical explanations. And this is the part most people miss—Custodio's recent surgery and Sierra's young age might have influenced their decisions to use performance-enhancing drugs.
These suspensions highlight the ongoing battle against performance-enhancing substances in baseball. With three players already suspended this year, including Max Kepler for 80 games, the league is sending a strong message. But is it the right approach?
Do these bans serve as a fair deterrent, or do they unfairly target players who may have had extenuating circumstances? Share your thoughts in the comments below, and let's spark a thoughtful discussion on this complex issue.
